Obstructive sleep apnea (OSA) is associated with an increased risk for cardiovascular disease (CVD) in adults, even those younger than 40 years, according to a study published online June 6 in the ...

The result? More than half of those who took part n in the study met the threshold of having sleep apnea. “It’s a two-stage ...

Sleep apnea affects millions of people worldwide and prevents them from getting quality sleep. It negatively affects patients ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people with OSA don't sleep well, they are at a higher risk for motor vehicle ...

Postmenopausal sleep issues contribute to a sharp decline in sleep quality among older women, beginning at approximately 51 ...

From sleep apnea notifications to a number of new health and fitness tools, WatchOS 11 adds a lot of new functionality to your Apple Watch. Here are some of the most notable features.

I was a terrible sleeper, so I spent a year throwing a bunch of smart tech at the problem, and it actually worked. Here’s ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

The next day those participants remembered more in a test of learning and recalling word pairs. “We can enhance memory, but we’re not making them sleep longer or necessarily shorter,” says Zee.

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug ...